Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
LeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsShares IssuedShares OutstandingShares Outstanding
Ratios

Viking Therapeutics (VKTX) Shares Issued (2016 - 2026)

Viking Therapeutics (VKTX) has disclosed Shares Issued for 12 consecutive years, with $450000.0 as the latest value for Q1 2026.

  • For Q1 2026, Shares Issued rose 28.94% year-over-year to $450000.0; the TTM value through Mar 2026 reached $2.1 million, down 67.11%, while the annual FY2025 figure was $2.0 million, 80.77% down from the prior year.
  • Shares Issued hit $450000.0 in Q1 2026 for Viking Therapeutics, down from $664000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $4.4 million in Q1 2024 and bottomed at -$200000.0 in Q4 2023.
  • Average Shares Issued over 5 years is $1.3 million, with a median of $587000.0 recorded in 2024.
  • On a YoY basis, Shares Issued climbed as much as 2995.24% in 2023 and fell as far as 233.33% in 2023.
  • Viking Therapeutics' Shares Issued stood at $150000.0 in 2022, then tumbled by 233.33% to -$200000.0 in 2023, then surged by 393.5% to $587000.0 in 2024, then grew by 13.12% to $664000.0 in 2025, then crashed by 32.23% to $450000.0 in 2026.
  • According to Business Quant data, Shares Issued over the past three periods came in at $450000.0, $664000.0, and $480000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.